HPTN 083 data from AIDS 2020: Virtual on long-acting injectable cabotegravir vs daily TDF/FTC for PrEP in MSM and transgender women, reported by CCO
April 2020 data from Tsepamo study on NTD prevalence following dolutegravir and other ART exposure at conception from AIDS 2020 reported by CCO
Latest data from a pooled analysis of 4 trials of switching to BIC/FTC//TAF in patients aged 65 years or older from AIDS 2020 reported by CCO
Download CCO slides reviewing guidelines, key studies, and individual considerations for optimizing the use of current ART regimens to treat HIV
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.